120
K. Brandt et al. / Journal of Fluorine Chemistry 97 (1999) 115±125
(m), 930 (s), 845 (m), 726 (w), 671 (w), 635 (w), 515 (w),
1
data) for 235 re®ned parameters, S0.808, Áꢆmax
Ê Ê
481 (w). H NMR (CDCl3) ꢂ: 0.58 (s, 6H); 5.02 (s, 4H);
0.55 e A 3, Áꢆmin 0.50 e A 3, CCDC Nr. 410331.
6.82 (s, 2H) ppm. 13C NMR (CDCl3) ꢂ: 1.58 (q, 1J(C,H)
122.0 Hz); 108.71 (t, 1J(C,H)162.1 Hz); 119.36 (m);
120.33 (q, 1J(C,F)274.6 Hz); 121.57 (q, 1J(C,F)
267.0 Hz); 138.92 (d, 1J(C,H)158.3 Hz); 149.29 (s);
3.1.5. 1,1,1-Trifluoro-2-(trifluoromethyl)-4-(p-toluene-
sulfonylhydrazone)pent-2-ene (6a)
To a solution of 8.00 g (38.8 mmol) of 1 and 7.22 g
(38.8 mmol) of p-toluene-sulfonylhydrazine in acetonitrile
(100 ml) placed in a 250 ml ¯ask was added 2 ml concen-
trated hydrochloric acid. After 20 h at RT the solvent was
removed in vacuo and 14.22 g (38.0 mmol; 98%) of 6a was
obtained. (m.p. 1468C).
4
149.29 (s) ppm. 19F NMR (CDCl3) ꢂ: 55.39 (q, J(F,F)
4
7.8 Hz); 64.20 (q, J(F,F)7.8 Hz) ppm. MS, m/z (%):
468 (2/M ), 449 (1), 402 (1), 373 (1), 353 (2), 352 (2), 333
(2), 305 (8), 283 (5), 277 (13), 265 (2), 257 (8), 238 (6), 215
(15), 189 (21), 181 (32), 167 (48), 165 (7), 163 (6), 157 (4),
145 (12), 140 (39), 135 (13), 119 (14), 100 (4), 88 (8), 83
(29), 79 (13), 78 (8), 77 (100), 75 (21), 69 (15), 50 (8). 49
(16), 47 (12). C14H12F12O2Si (468.20) calculated: C, 35.8;
H, 2.5. Found: C, 33.3; H, 2.7.
IR (KBr-pellet) ꢁ (cm 1): 3233 (N±H) (w), 1683 (w),
1598 (w), 1395 (w), 1344 (w), 1298 (w), 1217 (w), 1160
(m), 1073 (w), 967 (w), 906 (w), 921 (w), 906 (w), 858 (m),
816 (m), 722 (m), 705 (w), 674 (m), 611 (w), 550 (m), 508
(w), 437 (w). 1H NMR (CDCl3) ꢂ: 1.98 (s, 3H); 1.98 (s, 3H);
3
3.1.4. 1,1,1-Trifluoro-2-(trifluoromethyl)-3-(p-toluene-
sulfonylhydrazine)-pent-4-one (5)
7.01 (s, 1H); 7.32 (d, 2H, J(H,H)8.2 Hz); 7.82 (d, 2H,
3J(H,H)8.2 Hz); 8.47 (s, 1H) ppm. 13C NMR (CDCl3) ꢂ:
To a solution of 2.00 g (9.7 mmol) of 1 and 1.8 g
(9.7 mmol) of p-toluene-sulfonylhydrazine in acetonitrile
(20 ml) placed in a 50 ml ¯ask were added 0.25 ml triethy-
lamine. After 20 h at RT the solvent was removed in vacuo
(10 3 torr) and 3.72 g (9.5 mmol; 98%) 5 was obtained.
(m.p. 1358C).
16.52
(q, 1J(C,H)129.7 Hz);
21.51
(q, 1J(C,H)
127.7 Hz); 128.79 (d, 1J(C,H)165.9 Hz); 130.38 (d,
1J(C,H)156.4 Hz); 136.60 (s); 143.15 (d,1J(C,H)
165.93); 145.51 (s); 148.45 (s) ppm. 19F NMR (CDCl3)
ꢂ: 58.11 (q, 4J(F,F)7.8 Hz); 64.04 (dq, 4J(F,H)
4
1.4 Hz, J(F,F)7.8 Hz) ppm. MS, m/z (%): 374 (M /6),
278 (1), 242 (2), 199 (17), 190 (15), 158 (3), 157 (33), 156
(9), 155 (30), 140 (7), 139 (22), 121 (18), 101 (12), 93 (9), 92
(39), 91 (100), 77 (8), 69 (17), 65, (38), 63 (9), 58 (2), 57 (3),
52 (3), 51 (12), 41 (5), 39 (20), 29 (5), 28 (8), 27 (4).
C13H12F6N2O2S (374.31) calculated: C, 41.7; H, 3.2; N, 7.4;
S, 8.5. Found: C, 41.9; H, 3.4; N, 7.7; S, 8.3.
IR (KBr-pellet) ꢁ (cm 1): 3278 (w), 3231 (N±H) (w),
1716 (C=O) (w), 1600 (w), 1373 (w), 1335 (w), 1292 (w),
1259 (w), 1224 (w), 1184 (w), 1164 (w), 1088 (w), 872 (w),
811 (w), 725 (w), 697 (w), 667 (w), 550 (w), 533 (w), 487
1
(w) H NMR (CDCl3) ꢂ: 2.23 (s, 3H); 2.37 (s, 3H); 3.57
3
3
(dspt, 1H, J(H,H)3.0 Hz, J(F,H)7.8 Hz); 6.20 (d, 1H,
1
3J(H,H)3.0 Hz); 7.27 (d, 2H, J(H,H)8.0 Hz); 7.70 (d,
Crystal data: C13H12F6N2O2S, M374.31, triclinic,
2H, 1J(H,H)8.5 Hz) ppm. 13C NMR (CDCl3) ꢂ: 21.97 (q,
1J(C,H)128.7 Hz); 27.47 (q, 1J(C,H)128.7 Hz); 49.25
(dspt, 1J(C,H)125.0 Hz, 2J(C,F)23.9 Hz); 67.14 (d,
1J(C,H)141.5 Hz); 128.72 (d, 1J(C,H)147.0 Hz);
129.39 (q, 1J(C,F)307.0 Hz); 130.12 (d, 1J(C,H)
136.0 Hz); 134.38 (s); 144.98 (s); 203.12 (s) ppm.
space group P1, a7.105(3), b8.447(3), c
ꢀ
Ê
14.215(5) A, ꢇ84.63(3), ꢃ88.35(3), ꢈ69.27(3)8, U
Ê 3
794.4(5) A , Z2, F(000)380, Dc1.565 Mg m 3, ꢄ(Mo-
Ka)0.277 mm 1. Colorless tablet (0.76Â0.25 Â0.22 mm),
2767 unique re¯ections (2ꢀmax508) of which 1893 had
Iꢀ2ꢅ(I). Terminal reliability indices were R10.078
[Iꢀ2ꢅ(I)], wR20.240 (all data) for 235 re®ned parameters,
19F NMR (CDCl3) ꢂ:
62.11 (dq, 3J(F,H)7.8 Hz,
3
3
4J(F,F)7.8 Hz); 64.33 (dq, 3J(F,H)7.8 Hz, 4J(F,F)
S0.993, Áꢆmax0.497 e A
,
Áꢆmin 0.471 e A
,
Ê
Ê
7.8 Hz) ppm. MS, m/z (%): 392 (M /1), 351 (1), 350 (3),
CCDC Nr. 410329.
349 (21), 278 (6), 246 (3), 237 (9), 195 (16), 193 (4), 172 (4),
171 (10), 159 (2), 158 (3), 157 (30), 156 (9), 155 (30), 150
(8), 141 (9), 140 (7), 139 (53), 134 (5), 133 (11), 131 (6), 129
(3), 108 (11), 107 (10), 93 (9), 92 (31), 91 (81), 89 (10), 86
(39), 79 (9), 78 (4), 77 (16), 65 (47), 59 (8), 58 (17), 51 (13),
45 (13), 44 (23), 43 (100), 42 (12), 41 (11), 40 (27), 30 (20),
29 (19), 28 (38), 27 (17). C13H14F6N2O3S (392.16) calcu-
lated: C, 39.7; H, 3.5; N, 7.1; S, 8.1. Found: C, 40.7; H, 3.8;
N, 7.7; S, 8.9.
3.1.6. 1,1,1-Trifluoro-2-(trifluoromethyl)-4-(20,40,60-
triisopropylbenzenesulfonylhydrazone)pent-
2-ene (6b)
To a solution of 8.00 g (38.8 mmol) of 1 and 11.7 g
(38.8 mmol) of 2,4,6-triisopropylbenzenesulfonylhydrazine
in acetonitrile (100 ml) placed in a 250 ml ¯ask was added
2 ml concentrated hydrochloric acid. After 20 h at RT the
solvent was removed and 14.22 g (38.0 mmol; 98%) of 6b
was obtained. (m.p. 778C).
Crystal data: C13H14F6N2O3S, M392.32, monoclinic,
space group P21/n, a15.134(4), b5.184(2), c21.537(6)
IR (KBr-pellet) ꢁ (cm 1): 3256 (N±H) (w), 2964 (w),
2120 (w), 1684 (w), 1601 (w), 1385 (m), 1306 (w), 1212
(w), 1165 (w), 1098 (w), 908 (w), 857 (w), 723 (w), 667 (m),
Ê
Ê 3
A, ꢃ99.173(7), U1668.0(10) A , Z4, F(000)800,
Dc1.562 Mg m 3, ꢄ(Mo-Ka)0.272 mm 1. Colorless
tablet (0.56Â0.26Â0.11 mm), 2167 unique re¯ections
(2ꢀmax558) of which 1007 had Iꢀ2ꢅ(I). Terminal relia-
bility indices were R10.063 [Iꢀ2ꢅ(I)], wR20.176 (all
1
591 (w), 513 (w), 457 (w). H NMR (CDCl3) ꢂ: 1.23 (d,
18H, 3J(H,H)6.7 Hz); 1.99 (s, 3H); 2.90 (spt, 2H,
3J(H,H)6.7 Hz); 4.18 (spt, 1H, 3J(H,H)6.7 Hz); 6.96